Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA-Reference-Cited by-同舟云学术

Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

Published:2001-03-01 Issue:5 Volume:166 Page:2953-2960
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Heiser Axel,Maurice Margaret A.,Yancey Donna R.,Wu Ning Z.,Dahm Philipp,Pruitt Scott K.,Boczkowski David,Nair Smita K.,Ballo Michael S.,Gilboa Eli,Vieweg Johannes

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference27 articles.

1. Human Dendritic Cells Transfected with RNA Encoding Prostate-Specific Antigen Stimulate Prostate-Specific CTL Responses In Vitro

2. Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity

3. The Telomerase Catalytic Subunit Is a Widely Expressed Tumor-Associated Antigen Recognized by Cytotoxic T Lymphocytes

4. How much longer will tumour cells fool the immune system?

5. The Makings of a Tumor Rejection Antigen

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges of targeting tumor microenvironment in prostate cancer;New Updates in Tumor Microenvironment [Working Title];2024-08-14

2. Vaccines as treatments for prostate cancer;Nature Reviews Urology;2023-03-06

3. The Quest for mRNA Vaccines;Nucleic Acid Therapeutics;2022-12-01

4. Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects;Vaccines;2022-11-25

5. Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines;Life Sciences;2021-04